Sundance Strategies (SUND) 10-K/A 21 Jul 14 2014 FY Annual report (amended) Financial data

DOCUMENT_AND_ENTITY_INFORMATIO

DOCUMENT AND ENTITY INFORMATION (USD $)	12 Months Ended
	Mar. 31, 2014	Jul. 15, 2014	Sep. 30, 2013
Document And Entity Information [Abstract]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Mar-14	'	'
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Registrant Name	'Sundance Strategies, Inc.	'	'
Entity Central Index Key	'0001171838	'	'
Current Fiscal Year End Date	'--03-31	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Common Stock, Shares Outstanding	'	43,155,941	'
Entity Public Float	'	'	$53,122,420

Consolidated_Balance_Sheet

Consolidated Balance Sheet (USD $)	Mar. 31, 2014	Mar. 31, 2013
Current Assets	'	'
Cash and Cash Equivalents	$375,212	$545,417
Prepaid Expenses	2,000	'
Total Current Assets	377,212	545,417
Other Assets	'	'
Investment in Net Insurance Benefits	12,243,411	6,299,000
Advance for Investment in Net Insurance Benefits	3,584,862	'
Note Receivable	861,000	'
Accrued Interest Income	13,767	'
Total Other Long-term Assets	16,703,040	6,299,000
Total Assets	17,080,252	6,844,417
Current Liabilities	'	'
Accounts Payable and Accrued Expenses	52,915	93,082
Notes Payable	'	2,999,000
Notes Payable-related party	90,000	3,441
Total Current Liabilities	142,915	3,095,523
Long-term Liabilities	'	'
Notes Payable	1,455,904	'
Total Liabilities	1,598,819	3,095,523
Stockholders' Equity	'	'
Preferred Stock, authorized 10,000,000 shares, par value $0.001; no shares issued and outstanding	'	'
Common Stock, authorized 500,000,000 shares, par value $0.001; 43,015,941 and 40,797,441 shares issued and outstanding	43,017	40,798
Subscription Receivable	-1,500	-37,510
Additional Paid In Capital	15,050,705	3,850,257
Additional Paid In Capital Stock to be Issued	700,000	'
Accumulated Deficit	-310,789	-104,651
Total Stockholders' Equity	15,481,433	3,748,894
Total Liabilities and Stockholders' Equity	$17,080,252	$6,844,417

Consolidated_Balance_Sheet_Par

Consolidated Balance Sheet (Parenthetical) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Consolidated Balance Sheets [Abstract]	'	'
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, par value per share	$0.00	$0.00
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, shares authorized	500,000,000	500,000,000
Common Stock, par value per share	$0.00	$0.00
Common Stock, shares issued	43,015,941	40,797,441
Common Stock, shares outstanding	43,015,941	40,797,441

Consolidated_Statement_of_Oper

Consolidated Statement of Operations (USD $)	2 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2014
Consolidated Statement of Operations [Abstract]	'	'
Interest Income on Investment in Net Insurance Benefits	'	$508,411
General and Administrative Expenses	98,074	2,278,009
Loss from Operations	-98,074	-1,769,598
Other Income (Expense)	'	'
Gain on Extinguishment of Debt	'	1,672,124
Interest Income	'	13,788
Interest Expense	-6,577	-122,452
Total Other Income (Expense)	-6,577	1,563,460
Loss Before Income Taxes	-104,651	-206,138
Net Loss	($104,651)	($206,138)
Basic:	'	'
Loss Per Share	($0.01)	($0.01)
Weighted Average Number of Shares Outstanding	35,469,179	42,559,660
Diluted:	'	'
Loss Per Share	($0.01)	($0.01)
Weighted Average Number of Shares Outstanding	35,469,179	42,559,660

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholders' Equity (USD $)	Total	Common Stock [Member]	Additional Paid In Capital [Member]	Receivable for Common Stock Subscribed [Member]	Retained Earnings (Accumulated Deficit) [Member]
Balance at Jan. 30, 2013	'	'	'	'	'
Balance, shares at Jan. 30, 2013	'	'	'	'	'
Common Stock issued to founders	'	33,275	'	-33,275	'
Common Stock issued to founders, shares	'	33,275,000	'	'	'
Recapitalization with merger	-15,195	3,760	-18,955	'	'
Recapitalization with merger, shares	'	3,760,072	'	'	'
Common Stock issued for cash	3,868,740	3,759	3,864,981	'	'
Common Stock issued for cash, shares	'	3,758,255	'	'	'
Common Stock issued for a subscription receivable	'	4	4,231	-4,235	'
Common Stock issued for a subscription receivable, shares	'	4,114	'	'	'
Net Loss	-104,651	'	'	'	-104,651
Balance at Mar. 31, 2013	3,748,894	40,798	3,850,257	-37,510	-104,651
Balance, shares at Mar. 31, 2013	40,797,441	40,797,441	'	'	'
Common Stock issued for cash	11,092,500	2,219	11,090,281	'	'
Common Stock issued for cash, shares	2,218,500	2,218,500	'	'	'
Stock issuance costs	-841,651	'	-845,886	-4,235	'
Cash for shares to be issued	700,000	'	700,000	'	'
Cash received for subscription receivable	31,775	'	'	'	'
Amortization of options issued for compensation	816,802	'	816,802	'	'
Amortization of warrants issued for services	139,251	'	139,251	'	'
Net Loss	-206,138	'	'	'	-206,138
Balance at Mar. 31, 2014	$15,481,433	$43,017	$15,750,705	($1,500)	($310,789)
Balance, shares at Mar. 31, 2014	43,015,941	43,015,941	'	'	'

Consolidated_Statement_of_Cash

Consolidated Statement of Cash Flows (USD $)	2 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2014
OPERATING ACTIVITIES	'	'
Net Loss	($104,651)	($206,138)
Adjustments to reconcile to cash from operating activities:	'	'
Gain on Extinguishment of Debt	'	-1,672,124
Share Based Compensation - Options	'	816,802
Advance for Investments in Net Insurance Benefits	'	-3,584,862
Accrued Interest Income	'	-13,767
Prepaid Expenses	'	-2,000
Accounts Payable and Accrued Expenses	81,328	135,420
Investment in Net Insurance Benefits	-3,300,000	-5,944,411
Net Cash from Operating Activities	-3,323,323	-10,471,080
INVESTING ACTIVITIES	'	'
Notes Receivable	'	-861,000
Net Cash from Investing Activities	'	-861,000
FINANCING ACTIVITIES	'	'
Common Stock issued for cash	3,868,740	10,461,875
Cash from Common Stock to be Issued	'	700,000
Net Cash from Financing Activities	3,868,740	11,161,875
NET CHANGE IN CASH	545,417	-170,205
CASH AT BEGINNING OF PERIOD	'	545,417
CASH AT END OF PERIOD	545,417	375,212
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: NON CASH FINANCING ACTIVITIES:	'	'
Common Stock Issued for Subscription Receivable	37,510	'
Net Insurance Benefits Purchased with Debt	2,999,000	'
Liabilities Assumed through the Merger	15,195	'
Fair Value of Warrants Issued as Stock Issuance Costs	'	$139,251

ORGANIZATION_AND_BASIS_OF_PRES

ORGANIZATION AND BASIS OF PRESENTATION	12 Months Ended
	Mar. 31, 2014
ORGANIZATION AND BASIS OF PRESENTATION [Abstract]	'
ORGANIZATION AND BASIS OF PRESENTATION	'
	(1) ORGANIZATION AND BASIS OF PRESENTATION
	Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, for the purpose of selling coffee and other related items to the general public from retail coffee shop locations. These endeavors ceased in 2006, and it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. ("ANEW LIFE"), a subsidiary of Sundance Strategies, Inc. ("Sundance Strategies," the "Company" or "we"). The Company is a specialty financial services company which is engaged in the secondary market for life insurance known generally as "life settlements." The Company purchases the net insurance benefit contracts ("NIB") on life insurance policies between the sellers and purchasers, but does not take possession or control of the policies. The purchasers acquire the life insurance policies at a discount to their face value for investment purposes. The purchasers have available credit to pay premiums and expenses on the underlying policies until settlement. On settlement, the Company receives the NIB after all borrowings, interest and expenses have been paid out of the settlement proceeds.
	Merger
	On March 29, 2013, Sundance Strategies, Inc., a Nevada corporation ("Sundance Strategies"), its newly formed and wholly-owned subsidiary, Anew Acquisition Corp., a Utah corporation ("Merger Subsidiary"), and ANEW LIFE, INC., a Utah corporation ("ANEW LIFE"), completed an Agreement and Plan of Merger (the "Merger Agreement"), whereby the Merger Subsidiary merged with and into ANEW LIFE, and ANEW LIFE was the surviving company under the merger and became a wholly-owned subsidiary of Sundance Strategies on the closing of the merger (the "Merger"). Accordingly, Sundance Strategies issued 37,037,369 shares of its common stock in exchange for all of the outstanding shares of common stock of ANEW LIFE. ANEW LIFE had no other outstanding stock options, warrants, preferred stock or securities on the closing of the Merger. As of March 31, 2013, there were 40,797,441 shares of Sundance Strategies common stock outstanding, of which approximately 90.7% was held by the former shareholders of ANEW LIFE. The Merger has been treated as a reverse acquisition and a recapitalization of a public company. Accordingly, the historic financial statements of the Company are the historic financial statements of ANEW LIFE, which was incorporated on January 31, 2013.

CORRECTION_OF_AN_ERROR_RELATED

CORRECTION OF AN ERROR RELATED TO THE ADOPTION OF AN ACCOUNTING PRINCIPLE	12 Months Ended
	Mar. 31, 2014
CORRECTION OF AN ERROR RELATED TO THE ADOPTION OF AN ACCOUNTING PRINCIPLE [Abstract]	'
CORRECTION OF AN ERROR RELATED TO THE ADOPTION OF AN ACCOUNTING PRINCIPLE	'
	(2) CORRECTION OF AN ERROR RELATED TO THE ADOPTION OF AN ACCOUNTING PRINCIPLE
	On January 1, 2014, the Company changed its method of accounting for investment in NIBs, including the basis of recognizing income in investment in NIBs.  Prior to January 1, 2014, the Company utilized ASC 325-30 (Insurance Contracts), which allows for the investment in NIBs to be carried at cost and recognition of income at the time of death of the insured in the underlying life insurance contract.  Prior to January 1, 2014, no death of an insured had occurred and, therefore, no income had been recognized since inception of the Company.  On January 1, 2014, the Company adopted ASC 325-40 (Beneficial Interests in Securitized Financial Assets), which allows for the investment in NIBs to be carried at the initial investment value increased for interest income and decreased for cash receipts received by the Company and income recognized as accretable yield on investment in NIBs over the life of the underlying pools of life insurance contracts.  The adoption of ASC 325-40, which is the correction of an error, had no impact on the financial statements of the Company for the year ended March 31, 2014, and the period from January 1, 2013 (inception) through March 31, 2013.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Mar. 31, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	(3) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Estimates, The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Specifically, interest income on investment in NIBs is recognized in accordance with ASC 325-40. Under ASC 325-40, at the time of purchase, the Company estimates the future expected cash flows and determines the effective interest rate based on these estimated cash flows and our initial investment. Subsequent to the purchase and on a quarterly basis, these estimated cash flows are updated and a revised yield is calculated prospectively based on the current amortized cost of the investment. In estimating these cash flows, there are a number of assumptions that are subject to uncertainties and contingencies. These include the amount and timing of projected net cash receipts, expected maturity events, counter party performance risk, life expectancy estimates and their relation to premiums, interest, and other costs incurred, among other items. These uncertainties and contingencies are difficult to predict and are subject to future events that may impact our estimates and interest income. As a result, actual results could differ significantly from those estimates.
	Cash and Cash Equivalents, For purposes of reporting cash flows, the Company considers all highly-liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.
	Income Recognition, Interest income on investment in NIBs represents the excess of all cash flows attributable to the investment in net insurance benefits greater than the initial investment over the life of each pool of net insurance benefits using the effective yield method.  Changes in the estimate of expected cash flows from investments in NIBs are adjusted prospectively.
	During the period from April 1, 2013 through December 31, 2013, the Company's investment in NIBs was on non-accrual status. This decision was primarily based on the initial incremental uncertainty experienced by the Company during these first three quarters after closing on the first pool of NIBS.  Management concluded these uncertainties were significantly mitigated in the fourth quarter as additional experience and information was obtained, including the observation of the proper functioning of the entire system in response to the death of an insured in the fourth quarter.  Non-accrual status was removed effective January 1, 2014.
	Basic and Diluted Net Income (Loss) Per Common Share, Basic net income (Loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the periods presented. Diluted net income (loss) per common share is computed by including common shares that may be issued subject to existing rights with dilutive potential, when applicable.
	Investment in Net Insurance Benefits, The Company accounts for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company. The investment in NIBs is a residual economic beneficial interest in a portfolio of life insurance contracts that have been financed by an independent third party via a loan from a senior lender and insured via a mortality risk insurance product or mortality re-insurance ("MRI").  Profit is defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment, and service provider or other third-party payments.  The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company's balance sheet does not increase when premiums or other expenses are paid.   The Company holds a 100% interest in the NIBs relating to the underlying life insurance policies as of March 31, 2014, and 2013.
	We evaluate the carrying value of our investment in NIBS for impairment on a regular basis and, if necessary, adjust our total basis in the NIBs using new or updated information that affects our assumptions about remaining life expectancy, credit worthiness of the policy issuer, funds needed to maintain the asset until maturity, discount rates and potential return. We recognize impairment on a NIB contract if the expected discounted cash flows are less than the carrying amount of the investment, plus anticipated undiscounted future premiums and direct external costs, if any. Impairment of the NIBs could be generally caused by the insured significantly exceeding the estimate of the original life expectancy, which causes the original policy costs and projected future premiums to exceed the estimated maturity value, a change in credit worthiness of the policy issuer, increased or changes to applicable regulation of the investment, shortage of funds needed to maintain the asset until maturity and changes in discount rates. There are also risks associated with the policy holder's ability to repay such financing and the occurrence of events of default under such financing. We have not recognized any impairment from January 31, 2013 (inception), to the periods ended March 31, 2014.
	Income Taxes, The Company accounts for income taxes under FASB ASC 740, "Income Taxes". Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Accounting standards require the consideration of a valuation allowance for deferred tax assets if it is "more likely than not" that some component or all of the benefits of deferred tax assets will not be realized.
	The tax effects from an uncertain tax position can be recognized in the financial statements only if the position is more likely than not of being sustained if the position were to be challenged by a taxing authority. The Company has examined the tax positions taken in its tax returns and determined that there are no uncertain tax positions. As a result, the Company has recorded no uncertain tax liabilities in its balance sheet.
	Principles of Consolidation, The consolidated financial statements include the accounts of the Company and its subsidiary. The subsidiary is wholly owned. All material intercompany accounts and transactions are eliminated in consolidation.

NEW_ACCOUNTING_PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS	12 Months Ended
	Mar. 31, 2014
NEW ACCOUNTING PRONOUNCEMENTS [Abstract]	'
NEW ACCOUNTING PRONOUNCEMENTS	'
	(4) NEW ACCOUNTING PRONOUNCEMENTS
	The Company has reviewed recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.

INVESTMENT_IN_NET_INSURANCE_BE

INVESTMENT IN NET INSURANCE BENEFITS	12 Months Ended
	Mar. 31, 2014
INVESTMENT IN NET INSURANCE BENEFITS [Abstract]	'
INVESTMENT IN NET INSURANCE BENEFITS	'
	(5) INVESTMENT IN NET INSURANCE BENEFITS
	The carrying value of the investment in NIBs totaled $12,243,411 as of March 31, 2014. The table below describes the underlying life insurance policies relating to our investment in NIBs at March 31, 2014:
	Policies With Remaining Life		Number of Interests		Face Value of
	Expectancy		in Life		Underlying
	(in years)		Settlement Contracts		Policies
	0-1			0	$	0
	2-Jan			0		0
	3-Feb			2		10,000,000
	4-Mar			1		15,000,000
	5-Apr			5		19,000,000
	Thereafter			24		168,023,734
	Total of all policies			32	$	212,023,734
	The face value of the underlying life insurance policies of $220,023,734, of which one policy matured on March 11, 2014, totaling $8,000,000, with a remaining $212,023,734, represents the total insurance settlement on the life insurance policies as of March 31, 2014, including the increase for certain policies that have return of premium provisions of $384,801. Effectively, as of March 31, 2014, the policy holders had paid $39,837,216 on policy premiums and other expenses on the insurance contracts. The policy holders are independent of the Company, and as separate entities there is a risk that such entities might not continue to pay the policy premiums and other expenses as has been done historically. The Company monitors the policy holders' ability to maintain the underlying policies, and in the event the policy holders are unable to make the required payments, the Company would evaluate whether to directly maintain the underlying policies through the policy holders or allow them to elapse. The policy holders currently have senior loan agreements and MRI reinsurance to cover these payments. As of March 31, 2014, none of the underlying policies have elapsed and the required payments remain current.
	The table below describes the future estimated premiums payments, other expenses and interest paid by external parties expected to be paid on the policies through the estimated death date as of March 31, 2014.  As noted above, there are significant estimates involved in the calculation of the premium payments, other expenses and interest amounts identified in the table below.  The following table does not include all of the estimation factors used by the Company in estimating expected net cash receipts for interest income calculation purposes, and is intended to only provide the estimated premium payments, other expenses and interest amounts related to the policies underlying the Company's NIBs:
	Year	Premiums	Expenses + Interest	Total
	Year 1	$      (6,523,872)	$      (4,247,938)	$    (10,771,810)
	Year 2	(7,083,417)	(5,339,068)	(12,422,486)
	Year 3	(6,876,304)	(4,735,870)	(11,612,174)
	Year 4	(6,370,450)	(4,468,117)	(10,838,567)
	Year 5	(7,044,696)	(4,470,945)	(11,515,641)
	Thereafter	(32,442,287)	(16,006,811)	(48,449,097)
	Total	$ (66,341,026)	$ (39,268,749)	$ (105,609,775)
	The projected premiums, interest and expenses were created using the expected remaining life expectancies on the policies and other key assumptions. The expenses and interest calculations were based on current senior lender interest rates, current reinsurance interest rates, origination fees, servicing fees and other custodial fees expected during the life of the investment. The senior lender provides the loans at a high rate of interest and loan payments are guaranteed by the MRI or reinsurance coverage. The policy holders receive ongoing fees and a percentage of death benefits when a policy matures which we included in the estimated expenses. The Company receives cash flows from its investments in NIBs after all other loan balances, costs and expenses are paid.
	A portion of our investment in net insurance benefits was purchased as part of a transfer agreement that was purchased for $5,999,000, with a portion paid in cash of $3,000,000 and the remainder covered by a secured note in the amount of $2,999,000. The note is secured by 50% of the NIBs, which will be reduced as future payments are made on the note. The Company paid $300,000 to consultants for arranging the purchase of the NIBs. In January 2014, the Company acquired $90.6 million net insurance benefits mentioned in Note 7 below totaling $5,436,000. As of March 31, 2014 and 2013, investments in Net Insurance benefits were as follows.
		2014	2013
	Beginning Balance	$                     6,299,000	$                                 -
	Additional investments	5,436,000	6,299,000
	Accretion of interest income	508,411	-
	Distributions of investments	-	-
	Impairment of investments	-	-
	Total	$                   12,243,411	$                     6,299,000

CASH_AND_CASH_EQUIVALENTS

CASH AND CASH EQUIVALENTS	12 Months Ended
	Mar. 31, 2014
CASH AND CASH EQUIVALENTS [Abstract]	'
CASH AND CASH EQUIVALENTS	'
	(6) CASH AND CASH EQUIVALENTS
	Cash and cash equivalents consists principally of currency on hand and demand deposits at commercial banks. The Company had $375,212 and $545,417 in cash and cash equivalents as of March 31, 2014, and 2013, respectively. The Company maintains non-interest bearing accounts at one financial institution. The accounts at this institution are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000.The Company does not have FDIC coverage on the entire amount of bank deposits. The Company believes this risk is minimal.

ADVANCE_FOR_INVESTMENT_IN_NET_

ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS	12 Months Ended
	Mar. 31, 2014
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract]	'
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS	'
	(7) ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS
	On June 7, 2013, the Company entered into an Asset Transfer Agreement (the "Del Mar ATA") with Del Mar Financial, S.a.r.l. ("Del Mar"). The Del Mar ATA involved the purchase of certain life settlement assets consisting of 100% of the legal and net beneficial ownership interest in a portfolio of life insurance policies (the "NIBs"), among other assets that are consideration and collateral for certain cash advances and expense payments made by the Company. The end result of the Del Mar ATA and the advance was not to purchase the NIBs provided as collateral, but instead to provide sufficient capital to Del Mar for the conversion of a portion of the NIBs and other potential NIBs into "Qualified NIBs" before the original due date of December 31, 2013, which has been extended to April 1, 2014, and then subsequently extended to September 30, 2014, having a combined face amount of $400,000,000, with "Qualified NIBs" meaning that the NIBs would have premium financing secured for up to five years; that any grouping of NIBs would have not less than 10 policies; that the average age of the insureds under the life insurance policies would be approximately 81 years; and that the NIBs would have mortality re-insurance coverage. All remaining NIBs that are not converted to "Qualified NIBs" and all other assets conveyed to the Company as collateral to assure delivery of the Qualified NIBs will be re-conveyed to Del Mar upon receipt of combined Qualified NIBs having a face amount equal to $400,000,000. In the event Del Mar is unable to provide the Qualified NIBs by the original date of December 31, 2013, which was extended to April 1, 2014, and then subsequently extended to September 30, 2014, the Company will have the option of selling any of the assets acquired up to a liquidated damages settlement payment equal to 100% of any cash payments made under the Del Mar ATA. If the full balance of Qualified NIBs is provided by Del Mar, the Company will have paid $20,000,000 of consideration, $8,000,000 of which would be in cash and the remaining $12,000,000 in promissory notes. Promissory notes may be issued, pro rata, as Qualified NIBs are received. The promissory notes have a two year term from the effective date and bear an interest rate of 4.0% per annum. Total interest and principal amounts are due upon maturity. Del Mar is continuing its efforts in delivering the Qualified NIBs. The Company has received $90,000,000 in Qualified NIBs under the Del Mar ATA.
	As part of the Del Mar ATA, the Company entered into a Structuring and Consulting Agreement with Europa Settlement Advisors Ltd. ("Europa Agreement" and "Europa"). The Company is required to pay a structuring fee of 1% of the face amount of the life insurance policies underlying all NIBs introduced and acquired, payable as follows: 50% of the fee on the delivery of the NIBs; and the remaining 50% being payable on the conversion of the NIBs to Qualified NIBs as defined in the Del Mar ATA. The total restructuring fee will be up to $4,000,000. In the event that any cash consideration by the Company under the Del Mar ATA exceeds the defined $8,000,000 cash threshold, the amount payable under the Europa Agreement will be reduced on a dollar for dollar basis for any such overage. The total purchase price will not exceed $24,000,000 under the Del Mar ATA, which is comprised of $12,000,000 in cash consideration and $12,000,000 in promissory notes.
	On October 29, 2013, the Company and Europa, with the agreement of Del Mar, amended the Europa Agreement and the Del Mar ATA to acknowledge that the total up front cash payment due from the Company under the Del Mar ATA and Europa Agreement shall not exceed $12,000,000; that the Company would receive a credit on a dollar for dollar basis of the cash payment and all costs and expenses paid under the Del Mar ATA over $8,000,000, against all fees due Europa under the Europa Agreement or the Del Mar ATA. In the event the Qualified NIBs delivered are less than $300,000,000 in face value under the DMF Agreement, Del Mar and Europa shall be jointly and severally liable for liquidated damages equal to the aggregate of the cash payment under the Del Mar ATA and all of the costs advanced, reduced by the pro rata percentage of the Qualified NIBs delivered and accepted by SSI, multiplied by two; and if at least $300,000,000 in Qualified NIBs are delivered and accepted, then the cash payment and all costs will not be doubled if they are paid within 90 days.
	On October 29, 2013, the Company also entered into an Exclusivity Agreement with the consultant to Europa under the Europa Agreement under which the Company advanced $25,000 to such consultant for services related to the purchase of Qualified NIBs associated with the $400,000,000 in life insurance policies under the Del Mar ATA.
	On January 14, 2014, the Company completed the closing of $90.6 million of Qualified NIBs. These Qualified NIBs are part of the $400 million transaction of additional NIBs in portfolios from the Company's second acquisition in June 7, 2013, related to the Del Mar ATA.
	As of March 31, 2014, the Company had advanced $9,020,862 in payments and covered expenses under the Del Mar ATA and Europa Agreement. The Company reclassified $5,436,000 of these advances as investments in net insurance benefits as part of the $90,600,000 NIBs becoming qualified and accepted by the Company in January 2014. As of March 31, 2014, the remaining balance in advances totaled $3,584,862.

NOTE_RECEIVABLE

NOTE RECEIVABLE	12 Months Ended
	Mar. 31, 2014
NOTE RECEIVABLE [Abstract]	'
NOTE RECEIVABLE	'
	(8) NOTE RECEIVABLE
	On October 23, 2013, the Company made a loan totaling $650,000 in the form of a note receivable to Del Mar. The note bears a 3% interest rate, compounding annually, with a maturity date of November 30, 2013. Payment of principal and interest was due in full on maturity date. At March 31, 2014, Del Mar owed the full amount of the original principal and $8,540 in accrued interest income and was in default. Subsequent to year end, the entire balance of the note receivable was collected. The note is expected to be applied toward the cash portion of the Del Mar ATA or a reduction to the $12,000,000 note on closing of the Del Mar ATA if not paid in full.
	On December 9, 2013, the Company made a loan totaling $211,000 in the form of a note receivable to Majestic Ventures S.a.r.l. The note bears an 8% interest rate, compounding annually, with a maturity date of December 18, 2016. Payment of principal and interest are due in full on maturity date. At March 31, 2014, Majestic had not paid any of the original principal and $5,227 in accrued interest income. The Company has a secondary security interest in certain assets of Majestic, which are participating life settlements.

COMMITMENTS_CONTINGENCIES_AND_

COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS	12 Months Ended
	Mar. 31, 2014
COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS [Abstract]	'
COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS	'
	(9) COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS
	Legal Proceedings
	On May 13, 2014, the Company was served with a summons and complaint filed in the Third Judicial District Court in Salt Lake County, State of Utah, where an unrelated party is seeking to void the replacement of a stock certificate alleged to be owned by the plaintiff and acquired for value or damages of $74,255.
	Lease Agreements
	Pursuant to a verbal lease agreement, we currently occupy approximately 275 square feet of office space located in Provo, Utah on a month-to-month basis. The total lease expense is approximately $1,000 per month, payable in cash.
	We also entered into a lease agreement on November 2013 to lease 6,000 square feet of office space on a month-to-month basis in Irvine, California. The total lease expense is approximately $12,000 per month, payable in cash, 50% of which is invoiced to Del Mar Financial and Europa.
	Rent expense for the year ended March 31, 2014, was $41,333.

PROVISION_FOR_INCOME_TAXES

PROVISION FOR INCOME TAXES	12 Months Ended
	Mar. 31, 2014
PROVISION FOR INCOME TAXES [Abstract]	'
PROVISION FOR INCOME TAXES	'
	(10) PROVISION FOR INCOME TAXES
	The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements to give effect to the temporary differences which may arise from differences in the bases of fixed assets, depreciation methods and allowances based on the income taxes expected to be payable in future years. Minimal development stage deferred tax assets arising as a result of net operating loss carry-forwards have been offset completely by a valuation allowance due to the uncertainty of their utilization in future periods. In the Company's opinion, it is uncertain whether we will generate sufficient taxable income in the future to fully utilize the net deferred tax asset. Accordingly, a full valuation allowance equal to the deferred tax asset has been recorded.
	The provision for income taxes consists of the following:
			2014	2013
	Current Taxes
		Federal	$                    -	$                     -
		State	-	-
	Deferred Taxes
		Federal	(485,850)	(40,814)
		Benefits of operating loss carryforwards	533,006	40,814
		State	(47,156)	-
	Total Provision		$                    -	$                     -
	The total deferred tax asset is calculated by multiplying a 37.3% marginal tax rate by the cumulative Net Operating Loss ("NOL") of $2,038,201, which will begin to expire in 2021. The total valuation allowance is equal to the total deferred tax asset less any associated deferred tax liabilities.
	The tax effects of significant items comprising the Company's net deferred taxes as of March 31, 2014 and 2013 were as follows:
		2014	2013
	Deferred Tax assets:
	Net operating loss carry forwards	$            760,250	$              40,814
	Stock and warrant compensation	356,608	-
	Valuation allowance	(303,518)	(40,814)
	Net deferred tax asset	813,340	-
	Deferred tax liability	-	-
	Investment in net insurance benefits	(813,340)	-
	Net deferred taxes	$                     -	$                     -
	The valuation allowance was $303,518 and $40,814 for the years ended March 31, 2014, and 2013, respectively.
	The income tax provision differs from the amount of income tax determined by applying the U.S. federal tax rate of 34% to pretax income from continuing operations for the period ended March 31, 2014, and 2013 due to the following:
		2014	2013
	Income tax benefit at U. S. federal statutory rates:	$            (70,087)	$           (35,581)
	State tax, net of federal benefit	(6,803)	(5,233)
	Permanent and other differences	2,395	-
	Net operating losses	-188,209	-
	Change in valuation allowance	262,704	40,814
		$                     -	$                     -
	The Company has no tax positions at March 31, 2014, and 2013, for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility.
	The Company recognizes interest accrued relative to unrecognized tax benefits in interest expense and penalties in operating expense. During the period from January 31, 2013 (date of inception), through March 31, 2014, the Company recognized no income tax related interest and penalties. The Company had no accruals for income tax related interest and penalties at March 31, 2014, and 2013.
	The tax years 2011 through 2014 remain open to examination for federal income tax purposes and by other major taxing jurisdictions to which we are subject.

RELATED_PARTY_PAYABLES

RELATED PARTY PAYABLES	12 Months Ended
	Mar. 31, 2014
RELATED PARTY PAYABLES [Abstract]	'
RELATED PARTY PAYABLES	'
	(11) RELATED PARTY PAYABLES
	At March 31, 2014, and 2013, the Company owed $90,000 and $3,441 to related parties (officers and directors) for expenses paid on behalf of the Company. The Company paid the entire $3,441 balance of these related party transactions as of March 31, 2014.
	During the month of January 2014, the Company borrowed two short-term notes from two related parties bearing no interest and are payable on demand. The first note was entered into on January 8, 2014, in the amount of $50,000. The second note was entered into on January 13, 2014, in the amount of $40,000. At March 31, 2014, the Company owed the full $90,000 of the original principal.

NOTES_PAYABLE

NOTES PAYABLE	12 Months Ended
	Mar. 31, 2014
NOTES PAYABLE [Abstract]	'
NOTES PAYABLE	'
	(12) NOTES PAYABLE
	On March 11, 2013, the Company purchased an interest in NIBs totaling $5,999,000, with a portion paid in cash of $3,000,000 and the remainder covered by a secured note in the amount of $2,999,000. The note bears a compounding per annum interest rate of 4% with an original maturity date of December 31, 2013, which was amended to April 11, 2015. Payment of principal and interest are due in full on maturity date. The note is secured by 50% of the NIBs. The lender has first priority status on benefits paid and the percentage secured decreases as payments are made on the note. At March 31, 2014, the Company owed the full amount of the original principal and $129,028 in accrued interest.
	On November 5, 2013, the Company entered into an Amended and Restated Promissory Note (the "Amended Note") that amended the $2,999,999 secured note from the Company's initial purchase of NIBs. The Amended Note was payable to Del Mar rather than its initial payee and provided that notwithstanding anything therein or in any agreement referenced therein to the contrary, once accrued interest and $1,500,000 has been paid, the Amended Note shall be deemed to be paid in full, and all collateral shall be the sole and separate property of the Company, without exception. The Company may set off any claim it has against holder in payment of the Amended Note, without qualification. Any net death benefit or bond proceeds paid to maker or the Company in connection with the assets purchased under its PCH NIBs Transfer Agreement dated March 11, 2013, shall be used to prepay the Amended Note; provided, however, no such death benefits or bond proceeds paid to the maker or the Company shall be accounted for in any manner that would cause the Company to not receive the full benefit of the reductions of the principal balance of the Amended Note.
	The Company assessed the impact of the amendment of the $2,999,000 secured note and whether it should be accounted for as an extinguishment of debt and the issuance of new debt or a modification of the existing debt under ASC 470-50. The present value of the remaining payments on the new promissory note was substantially different than the present value of the original note. Therefore the Company reported the transaction as an extinguishment of debt. Since the exchange was accounted for as an extinguishment of debt, the decrease in fair value of the Company's liabilities was reported as a gain on extinguishment of debt on the consolidated statement of operations.
	On November 5, 2013, the Amended Note was assigned by the Company to Del Mar; Del Mar assigned it to another party for $1,000,000 retaining a buyback option (the "Buyback Option") for a period of 12 months from the date of the assignment of the Amended Note to buy back the Amended Note at a price equal to the $1,000,000, plus an additional 2.0% for each month (whole or partial) that had elapsed from the date of the assignment to the date that the Buyback Option is exercised (the "Buyback Price"). Further, notwithstanding the foregoing, the Buyback Price shall in no circumstances be less than an amount equal to $1,120,000 (the "Minimum Buyback Price"). The Company acquired this Buyback Option from Del Mar on the same date, with the provision that it would revert to Del Mar if it had delivered and the Company had accepted $400,000,000 of Qualified NIBs under the Del Mar ATA.

STOCK_OPTIONS

STOCK OPTIONS	12 Months Ended
	Mar. 31, 2014
STOCK OPTIONS [Abstract]	'
STOCK OPTIONS	'
	(13) STOCK OPTIONS
	On April 1, 2013, the Company granted a 5,000 share stock option to a former director, Jini Suttner. Ms. Suttner was a founder and a director of ANEW LIFE and was designated as a director of Sundance Strategies on the closing of the ANEW LIFE Merger on March 29, 2013, but resigned on April 1, 2013. The stock option was granted as compensation for her service, in conjunction with its planned adoption of a stock option or similar plan to be adopted in the near future for the benefit of employees, officers and directors that will outline the terms and conditions of the stock option which will not have any effect on the grant date, the exercise price or vesting that have been approved. The stock option has an exercise price of $0.77 per share, which vested immediately, and a contractual term of five years.
	The Company valued these options using the Black-Scholes option pricing model applying the simplified method for the expected term under the following assumptions: $1.0294 market price, $0.77 exercise price, 2.5 years expected life, 73% expected volatility, 0.30% risk free rate.
	On April 5, 2013, the Company issued 1,700,000 stock options to certain officers, employees and members of the Board of Directors of the Company and in conjunction with its planned adoption of a stock option or similar plan to be adopted in the near future for the benefit of employees, officers and directors, not, however, to have any effect on the grant date, the exercise price or vesting that have been approved. The stock options have an exercise price of $0.77 per share. All options have a contractual term of five years.
	Of the 1,700,000 stock options, 1,500,000 stock options vest in several tranches, wherein 937,500 vested on the grant date, and the remaining 562,500 stock options vest in equal tranches of 187,500 stock options on the grant date anniversary for the following three years. The Company valued the 1,500,000 options using the Black-Scholes option pricing model applying the simplified method under the following assumptions: $1.0294 market price, $0.77 exercise price, 3.5 years expected life, 68% volatility, 0.51% risk free rate.
	The remaining 200,000 stock options granted vest in several tranches, wherein 50,000 vested as of the grant date, and the remaining 150,000 stock options vesting in equal tranches on the grant date anniversary for the following three years. The Company valued the 200,000 options using the Black-Scholes option pricing model applying the simplified method under the following assumptions: $1.0294 market price, $0.77 exercise price, 3.5 years expected life, 68% volatility, 0.51% risk free rate.
	On April 5, 2013, the Company also issued 80,000 stock options to non-employees which vested immediately. The Company records the stock-based compensation awards issued to non-employees and other external entities for goods and services at either the fair market value of the goods received or services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in FASB ASC 505-50-30. The Company valued the 80,000 options using the Black-Scholes option pricing model under the following assumptions: $1.0294 market price, $0.77 exercise price, 5 years expected life, 79% volatility, 0.68% risk free rate.
	On October 11, 2013, the Company issued 400,000 stock options to an employee in conjunction with its planned adoption of a stock option or similar plan to be adopted in the near future for the benefit of employees, officers and directors The stock options have an exercise price of $5.00 per share. The options have a contractual term of five years.
	The 400,000 stock options vest in several tranches, wherein 10% of the options vesting six months after the date of issuance and the remaining options to vest monthly over the next 36 months subject to continuing employment with the Company. The Company valued the 400,000 options using the Black-Scholes option pricing model applying the simplified method under the following assumptions: $5.00 market price, $5.00 exercise price, 3.40 years expected life, 68% volatility, 0.76% risk free rate.
	The Company has recorded stock-based compensation expense of $816,802 related to these options for year ended March 31, 2014.
	Date Issued	Number of Options	Weighted Average Exercise Price		Weighted Average Grant Date Fair Value		Remaining Contractual Term	Value if Exercised
	Balance March 31, 2013	-	$	-	$	-	-	$	-
	Granted	2,185,000		1.54		0.97	4.50		3,374,450
	Exercised	-		-		-	-		-
	Cancelled/Expired	-		-		-	-		-
	Outstanding as of March 31, 2014	2,185,000	$	1.54	$	0.97	4.50	$	3,374,450
	Exercisable as of  March 31, 2014	1,072,500	$	1.54	$	0.97	4.50	$	1,656,338
	The remaining $1,162,745 will be recognized ratably over the weighted average service period of 2.38 years.

WARRANTS

WARRANTS	12 Months Ended
	Mar. 31, 2014
WARRANTS [Abstract]	'
WARRANTS	'
	(14) WARRANTS
	On April 8, 2013, the Company approved a private placement of its common stock that provided for the payment of introduction fees in the form of cash and warrants and later amended. As a result of investments totaling $7,000,000 in this private offering by persons introduced to the Company, the Company authorized the issuance of 70,000 warrants to purchase 70,000 shares of the Company's common stock. The warrants have an exercise price of $5.00 per share and have a contractual life of two years from the effective date of the funds invested in the offering by the parties introduced to the Company, which was May 31, 2013. The Company recorded $139,251 in stock issuance costs related to the warrants as of March 31, 2014.
	The Company valued the 70,000 warrants using the Black-Scholes option pricing model under the following assumptions: $5.00 market price, $5.00 exercise price, 2 years expected life, 73% expected volatility, 0.30% risk free rate.
		Number of Options	Weighted Average Exercise Price		Weighted Average Grant Date Fair Value		Remaining Contractual Term	Intrinsic Value
	Outstanding as of March 31, 2013	-	$	-	$	-	-	$	-
	Granted	70,000		5.00		1.92	1.17		-
	Cancelled/Expired	-		-		-	-		-
	Outstanding as of March 31, 2014	70,000	$	5.00	$	1.92	1.17	$	-
	Exercisable as of March 31, 2014	70,000	$	5.00	$	1.92	1.17	$	-
	The Company recognized the full $139,251 as stock issuance costs during the year ended March 31, 2014.

STOCK_TRANSACTIONS

STOCK TRANSACTIONS	12 Months Ended
	Mar. 31, 2014
STOCK TRANSACTIONS [Abstract]	'
STOCK TRANSACTIONS	'
	(15) STOCK TRANSACTIONS
	Preferred Stock
	The Company has authorized 10,000,000 shares of its common stock at a par value of $0.001 per share. As of March 31, 2014, there were no preferred shares issued and outstanding.
	Common Stock
	As of March 31, 2014, the Company has 500,000,000 shares of common stock authorized with a par value of $0.001 per share and 43,015,941 shares of common stock issued and outstanding.
	On April 8, 2013, the Company approved a private offering of up to 3,000,000 common shares of restricted stock to investors at $5.00 per share. The purpose of the offering was to acquire additional NIBs. As of the March 31, 2014, the Company has collected $11,792,500 for 2,358,500 common shares at $5.00 per share of which 2,218,500 shares were issued for cash of $11,092,500 and 140,000 shares are to be issued for cash of $700,000; paid $841,651 in introduction fees; and issued two year warrants to acquire 70,000 shares of our common stock at an exercise price of $5.00 per share.

GOING_CONCERN

GOING CONCERN	12 Months Ended
	Mar. 31, 2014
GOING CONCERN [Abstract]	'
GOING CONCERN	'
	(16) GOING CONCERN
	The Company's financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. At March 31, 2014, the Company had accumulated losses of $310,789 and a working capital of $234,297, but has yet to receive cash payments on revenues. These factors raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.
	The Company's continued existence is dependent on its ability to generate sufficient cash flow to cover operating expenses and to invest in future operations. Management is actively pursuing opportunities to expand existing operations. The Company does not anticipate having adequate revenues from operations until three to four years, and until a revenue stream has been established, the Company will require debt or equity funding to fund its current and intended business. If management is unsuccessful in these efforts, discontinuance of operations is possible.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Mar. 31, 2014
SUBSEQUENT EVENTS [Abstract]	'
SUBSEQUENT EVENTS	'
	(17) SUBSEQUENT EVENTS
	On April 28, 2014, the Company received full payment of the $650,000 Del Mar note receivable entered into on October 23, 2013. Of the $650,000 the Company received cash payments totaling $550,000 and moved $100,000 applied to advances for investment in net insurance benefits.
	On June 24, 2014, the Company issued a private stock offering as part of the August 1, 2013 agreement to issue 660,000 shares at $5 per share for a total of $3,300,000.
	Effective June 26, 2014, the Company extended Del Mar's obligation to deliver Qualified NIBs under the Del Mar ATA to September 30, 2014, from April 1, 2014.
	On July, 2014, the Company issued the remaining 140,000 shares mentioned in footnote 14 that were paid for cash as advance subscriptions for $700,000.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)	12 Months Ended
	Mar. 31, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Estimates	'
	Estimates, The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Specifically, interest income on investment in NIBs is recognized in accordance with ASC 325-40. Under ASC 325-40, at the time of purchase, the Company estimates the future expected cash flows and determines the effective interest rate based on these estimated cash flows and our initial investment. Subsequent to the purchase and on a quarterly basis, these estimated cash flows are updated and a revised yield is calculated prospectively based on the current amortized cost of the investment. In estimating these cash flows, there are a number of assumptions that are subject to uncertainties and contingencies. These include the amount and timing of projected net cash receipts, expected maturity events, counter party performance risk, life expectancy estimates and their relation to premiums, interest, and other costs incurred, among other items. These uncertainties and contingencies are difficult to predict and are subject to future events that may impact our estimates and interest income. As a result, actual results could differ significantly from those estimates.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents, For purposes of reporting cash flows, the Company considers all highly-liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.
Income Recognition	'
	Income Recognition, Interest income on investment in NIBs represents the excess of all cash flows attributable to the investment in net insurance benefits greater than the initial investment over the life of each pool of net insurance benefits using the effective yield method.  Changes in the estimate of expected cash flows from investments in NIBs are adjusted prospectively.
	During the period from April 1, 2013 through December 31, 2013, the Company's investment in NIBs was on non-accrual status. This decision was primarily based on the initial incremental uncertainty experienced by the Company during these first three quarters after closing on the first pool of NIBS.  Management concluded these uncertainties were significantly mitigated in the fourth quarter as additional experience and information was obtained, including the observation of the proper functioning of the entire system in response to the death of an insured in the fourth quarter.  Non-accrual status was removed effective January 1, 2014.
Basic and Diluted Net Income (Loss) Per Common Share,	'
	Basic and Diluted Net Income (Loss) Per Common Share, Basic net income (Loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the periods presented. Diluted net income (loss) per common share is computed by including common shares that may be issued subject to existing rights with dilutive potential, when applicable.
Investment in Net Insurance Benefits	'
	Investment in Net Insurance Benefits, The Company accounts for its investment in NIBs at the initial investment value increased for interest income and decreased for cash receipts received by the Company. The investment in NIBs is a residual economic beneficial interest in a portfolio of life insurance contracts that have been financed by an independent third party via a loan from a senior lender and insured via a mortality risk insurance product or mortality re-insurance ("MRI").  Profit is defined as the net insurance proceeds from death benefits after senior debt repayment, mortality risk repayment, and service provider or other third-party payments.  The Company is not responsible for maintaining premiums or other expenses related to maintaining the underlying life insurance contracts. Therefore, the investment in NIBs balance on the Company's balance sheet does not increase when premiums or other expenses are paid.   The Company holds a 100% interest in the NIBs relating to the underlying life insurance policies as of March 31, 2014, and 2013.
	We evaluate the carrying value of our investment in NIBS for impairment on a regular basis and, if necessary, adjust our total basis in the NIBs using new or updated information that affects our assumptions about remaining life expectancy, credit worthiness of the policy issuer, funds needed to maintain the asset until maturity, discount rates and potential return. We recognize impairment on a NIB contract if the expected discounted cash flows are less than the carrying amount of the investment, plus anticipated undiscounted future premiums and direct external costs, if any. Impairment of the NIBs could be generally caused by the insured significantly exceeding the estimate of the original life expectancy, which causes the original policy costs and projected future premiums to exceed the estimated maturity value, a change in credit worthiness of the policy issuer, increased or changes to applicable regulation of the investment, shortage of funds needed to maintain the asset until maturity and changes in discount rates. There are also risks associated with the policy holder's ability to repay such financing and the occurrence of events of default under such financing. We have not recognized any impairment from January 31, 2013 (inception), to the periods ended March 31, 2014.
Income Taxes	'
	Income Taxes, The Company accounts for income taxes under FASB ASC 740, "Income Taxes". Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Accounting standards require the consideration of a valuation allowance for deferred tax assets if it is "more likely than not" that some component or all of the benefits of deferred tax assets will not be realized.
	The tax effects from an uncertain tax position can be recognized in the financial statements only if the position is more likely than not of being sustained if the position were to be challenged by a taxing authority. The Company has examined the tax positions taken in its tax returns and determined that there are no uncertain tax positions. As a result, the Company has recorded no uncertain tax liabilities in its balance sheet.
Principles of Consolidation	'
	Principles of Consolidation, The consolidated financial statements include the accounts of the Company and its subsidiary. The subsidiary is wholly owned. All material intercompany accounts and transactions are eliminated in consolidation.

INVESTMENT_IN_NET_INSURANCE_BE1

INVESTMENT IN NET INSURANCE BENEFITS (Tables)	12 Months Ended
	Mar. 31, 2014
INVESTMENT IN NET INSURANCE BENEFITS [Abstract]	'
Schedule of Investments in Net Insurance Benefit Contracts	'
	Policies With Remaining Life		Number of Interests		Face Value of
	Expectancy		in Life		Underlying
	(in years)		Settlement Contracts		Policies
	0-1			0	$	0
	2-Jan			0		0
	3-Feb			2		10,000,000
	4-Mar			1		15,000,000
	5-Apr			5		19,000,000
	Thereafter			24		168,023,734
	Total of all policies			32	$	212,023,734
Schedule of Future Estimated Premiums, Payments and Other Expenses Expected to be Paid on Insurance Benefit Contracts	'
	Year	Premiums	Expenses + Interest	Total
	Year 1	$      (6,523,872)	$      (4,247,938)	$    (10,771,810)
	Year 2	(7,083,417)	(5,339,068)	(12,422,486)
	Year 3	(6,876,304)	(4,735,870)	(11,612,174)
	Year 4	(6,370,450)	(4,468,117)	(10,838,567)
	Year 5	(7,044,696)	(4,470,945)	(11,515,641)
	Thereafter	(32,442,287)	(16,006,811)	(48,449,097)
	Total	$ (66,341,026)	$ (39,268,749)	$ (105,609,775)
Summary of Investments in Net Insurance Benefits	'
		2014	2013
	Beginning Balance	$                     6,299,000	$                                 -
	Additional investments	5,436,000	6,299,000
	Accretion of interest income	508,411	-
	Distributions of investments	-	-
	Impairment of investments	-	-
	Total	$                   12,243,411	$                     6,299,000

PROVISION_FOR_INCOME_TAXES_Tab

PROVISION FOR INCOME TAXES (Tables)	12 Months Ended
	Mar. 31, 2014
PROVISION FOR INCOME TAXES [Abstract]	'
Schedule of Provision for Income Taxes	'
			2014	2013
	Current Taxes
		Federal	$                    -	$                     -
		State	-	-
	Deferred Taxes
		Federal	(485,850)	(40,814)
		Benefits of operating loss carryforwards	533,006	40,814
		State	(47,156)	-
	Total Provision		$                    -	$                     -
Schedule of Net Deferred Taxes	'
		2014	2013
	Deferred Tax assets:
	Net operating loss carry forwards	$            760,250	$              40,814
	Stock and warrant compensation	356,608	-
	Valuation allowance	(303,518)	(40,814)
	Net deferred tax asset	813,340	-
	Deferred tax liability	-	-
	Investment in net insurance benefits	(813,340)	-
	Net deferred taxes	$                     -	$                     -
Schedule of Income Tax Rate Reconciliation	'
		2014	2013
	Income tax benefit at U. S. federal statutory rates:	$            (70,087)	$           (35,581)
	State tax, net of federal benefit	(6,803)	(5,233)
	Permanent and other differences	2,395	-
	Net operating losses	-188,209	-
	Change in valuation allowance	262,704	40,814
		$                     -	$                     -

STOCK_OPTIONS_Tables

STOCK OPTIONS (Tables)	12 Months Ended
	Mar. 31, 2014
STOCK OPTIONS [Abstract]	'
Schedule of Stock Option Activity	'
	Date Issued	Number of Options	Weighted Average Exercise Price		Weighted Average Grant Date Fair Value		Remaining Contractual Term	Value if Exercised
	Balance March 31, 2013	-	$	-	$	-	-	$	-
	Granted	2,185,000		1.54		0.97	4.50		3,374,450
	Exercised	-		-		-	-		-
	Cancelled/Expired	-		-		-	-		-
	Outstanding as of March 31, 2014	2,185,000	$	1.54	$	0.97	4.50	$	3,374,450
	Exercisable as of  March 31, 2014	1,072,500	$	1.54	$	0.97	4.50	$	1,656,338

WARRANTS_Tables

WARRANTS (Tables)	12 Months Ended
	Mar. 31, 2014
WARRANTS [Abstract]	'
Schedule of Warrant Activity	'
		Number of Options	Weighted Average Exercise Price		Weighted Average Grant Date Fair Value		Remaining Contractual Term	Intrinsic Value
	Outstanding as of March 31, 2013	-	$	-	$	-	-	$	-
	Granted	70,000		5.00		1.92	1.17		-
	Cancelled/Expired	-		-		-	-		-
	Outstanding as of March 31, 2014	70,000	$	5.00	$	1.92	1.17	$	-
	Exercisable as of March 31, 2014	70,000	$	5.00	$	1.92	1.17	$	-

ORGANIZATION_AND_BASIS_OF_PRES1

ORGANIZATION AND BASIS OF PRESENTATION (Details)	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2013
			Merger Subsidiary [Member]
			ANEW LIFE [Member]
			Common Stock [Member]
ORGANIZATION AND BASIS OF PRESENTATION [Abstract]	'	'	'
Common stock outstanding	43,015,941	40,797,441	'
Business Acquisition [Line Items]	'	'	'
Shares issued in business acquisition	'	'	37,037,369
Reverse merger, equity interests held by former shareholders	'	'	90.70%

INVESTMENT_IN_NET_INSURANCE_BE2

INVESTMENT IN NET INSURANCE BENEFITS (Narrative) (Details) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Jan. 30, 2013
INVESTMENT IN NET INSURANCE BENEFITS [Abstract]	'	'	'
Investment in Net Insurance Benefits	$12,243,411	$6,299,000	'
Contracts that matured during the period	8,000,000	'	'
Face value of Net Insurance Benefits	212,023,734	'	'
Total amount policy holders have paid on policy premiums and other expenses on insurance contracts	39,837,216	'	'
Return of premium provisions on investments in net insurance benefits	384,801	'	'
Face value of net insurance benefits purchased through pledge agreement	5,999,000	'	'
Amount of cash paid for the net insurance benefits purchased through pledge agreement	3,000,000	'	'
Capitalized consultant fee	5,436,000	'	'
Qualified net insurance benefits received	90,600,000	'	'
Secured Debt [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Face amount	$2,999,000	'	'

INVESTMENT_IN_NET_INSURANCE_BE3

INVESTMENT IN NET INSURANCE BENEFITS (Schedule of Investment in Net Insurance Benefit Contracts) (Details) (USD $)	Mar. 31, 2014
Number of Interests in Life Settlement Contracts:	'
Number of interests in life settlement contracts, next twelve months	0
Number of interests in life settlement contracts, year two	0
Number of interests in life settlement contracts, year three	2
Number of interests in life settlement contracts, year four	1
Number of interests in life settlement contracts, year five	5
Number of interests in life settlement contracts, thereafter	24
Number of interests in life settlement contracts, total	32
Face Value of Underlying Policies:	'
Face value of underlying policies, next twelve months	$0
Face value of underlying policies, year two	0
Face value of underlying policies, year three	10,000,000
Face value of underlying policies, year four	15,000,000
Face value of underlying policies, year five	19,000,000
Face value of underlying policies, thereafter	168,023,734
Face value of underlying policies, total	$212,023,734

INVESTMENT_IN_NET_INSURANCE_BE4

INVESTMENT IN NET INSURANCE BENEFITS (Schedule of Future Estimated Premiums Payments, Other Expenses and Interest Paid By External Parties) (Details) (USD $)	Mar. 31, 2014
Premiums:	'
Premiums to be paid, year one	$6,523,872
Premiums to be paid, year two	7,083,417
Premiums to be paid, year three	6,876,304
Premiums to be paid, year four	6,370,450
Premiums to be paid, year five	7,044,696
Premiums to be paid, thereafter	32,442,287
Premiums to be paid, total	66,341,026
Expenses + Interest:	'
Expense + Interest to be paid, year one	4,247,938
Expense + Interest to be paid, year two	5,339,068
Expense + Interest to be paid, year three	4,735,870
Expense + Interest to be paid, year four	4,468,117
Expense + Interest to be paid, year five	4,470,945
Expense + Interst to be paid, thereafter	16,006,811
Expense + Interest, total	39,268,749
Total Premiums, Interest and Expenses:	'
Total to be paid, year one	10,771,810
Total to be paid, year two	12,422,486
Total to be paid, year three	11,612,174
Total to be paid, year four	10,838,567
Total to be paid, year five	11,515,641
Total to be paid, thereafter	48,449,097
Premiums, interest and expenses, total	$105,609,775

INVESTMENT_IN_NET_INSURANCE_BE5

INVESTMENT IN NET INSURANCE BENEFITS (Summary of Investments in Net Insurance Benefits) (Details) (USD $)	2 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2014
INVESTMENT IN NET INSURANCE BENEFITS [Abstract]	'	'
Beginning Balance	'	$6,299,000
Additional investments	6,299,000	5,436,000
Accretion of interest income	'	508,411
Distributions of investments	'	'
Impairment of investments	'	'
Total	$6,299,000	$12,243,411

CASH_AND_CASH_EQUIVALENTS_Deta

CASH AND CASH EQUIVALENTS (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013	Jan. 30, 2013
CASH AND CASH EQUIVALENTS [Abstract]	'	'	'
Cash and Cash Equivalents	$375,212	$545,417	'
FDIC insurance maximum	$250,000	'	'

ADVANCE_FOR_INVESTMENT_IN_NET_1

ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS (Details) (USD $)	2 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2014
ADVANCE FOR INVESTMENT IN NET INSURANCE BENEFITS [Abstract]	'	'
Face value of net insurance benefits purchased under asset transfer agreement	'	$400,000,000
Face amount of net insurance benefits required to be delivered to the company per the asset transfer agreement	'	300,000,000
Total consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l.	'	20,000,000
Total cash consideration that would be paid by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l.	'	8,000,000
Face amount of promissory note that would be issued by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l.	'	12,000,000
Interest rate	'	4.00%
Note term	'	'2 years
Restructuring charges accrued	'	4,000,000
Advance for Investment in Net Insurance Benefits	'	3,584,862
Total purchase price	'	24,000,000
Maximum purchase price payable by promissory notes	'	12,000,000
Advanced payments under the Del Mar ATA	'	90,020,862
Additional investments	6,299,000	5,436,000
Advance to consultant for services	'	25,000
Qualified net insurance benefits received	'	$90,600,000

NOTE_RECEIVABLE_Details

NOTE RECEIVABLE (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2014
			Notes Receivable [Member]	Notes Receivable [Member]
			Del Mar [Member]	Majestic [Member]
NOTE RECEIVABLE [Abstract]	'	'	'	'
Face amount of promissory note that would be issued by the company if all net insurance benefits are provided under the asset transfer agreement with Del Mar Financial, S.a.r.l.	$12,000,000	'	'	'
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'	'	'
Face value of loan	'	'	650,000	211,000
Interest rate	'	'	3.00%	8.00%
Maturity date	'	'	30-Nov-13	18-Dec-16
Accrued interest receivable	$13,767	'	$8,540	$5,227

COMMITMENTS_CONTINGENCIES_AND_1

COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS (Details) (USD $)	12 Months Ended			1 Months Ended
	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	13-May-14
		Utah Office [Member]	California Office [Member]	Subsequent Event [Member]
		sqft	sqft
Loss Contingencies [Line Items]	'	'	'	'
Amount of claim filed against the company	'	'	'	$74,255
Lease Agreement [Line Items]	'	'	'	'
Monthly rental payment	'	1,000	12,000	'
Area	'	275	6,000	'
Rent expense	$41,333	'	'	'

PROVISION_FOR_INCOME_TAXES_Nar

PROVISION FOR INCOME TAXES (Narrative) (Details) (USD $)	12 Months Ended	14 Months Ended
	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2013
PROVISION FOR INCOME TAXES [Abstract]	'	'	'
Cumulative NOL	$2,038,201	$2,038,201	'
NOL beginning expiration date	31-Dec-21	'	'
Statutory federal tax rate	34.00%	'	'
Interest and penalties of income tax expense	'	0	'
Accrued interest and penalties	$0	$0	$0

PROVISION_FOR_INCOME_TAXES_Sch

PROVISION FOR INCOME TAXES (Schedule of Provision For Income Taxes) (Details) (USD $)	2 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2014
Current Taxes	'	'
Federal	'	'
State	'	'
Deferred Taxes	'	'
Federal	-40,814	-485,850
Deferred Other Tax Expense Benefit	40,814	533,006
State	'	-47,156
Total Provision	'	'

PROVISION_FOR_INCOME_TAXES_Sch1

PROVISION FOR INCOME TAXES (Schedule of Net Deferred Taxes) (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Deferred Tax assets:	'	'
Net operating loss carry forwards	$760,250	$40,814
Stock and warrant compensation	356,608	'
Valuation allowance	-303,518	-40,814
Net deferred tax asset	813,340	'
Deferred tax liability	'	'
Investment in net insurance benefits	-813,340	'
Net deferred taxes	'	'

PROVISION_FOR_INCOME_TAXES_Sch2

PROVISION FOR INCOME TAXES (Schedule of Effective Income Tax Rate Reconciliation) (Details) (USD $)	2 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2014
PROVISION FOR INCOME TAXES [Abstract]	'	'
Income tax benefit at U. S. federal statutory rates:	($35,581)	($70,087)
State Tax, net of Federal Benefit	-5,233	-6,803
Permanent and other differences	'	2,395
Net operating losses	'	-188,209
Change in valuation allowance	40,814	262,704
Total Provision	'	'

RELATED_PARTY_PAYABLES_Details

RELATED PARTY PAYABLES (Details) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
RELATED PARTY PAYABLES [Abstract]	'	'
Notes Payable-related party	$90,000	$3,441
Repayment of related party balance	3,441	'
Related Party Transaction [Line Items]	'	'
Amount of transaction	90,000	'
January 8, 2014 [Member]	'	'
Related Party Transaction [Line Items]	'	'
Amount of transaction	50,000	'
January 13, 2014 [Member]	'	'
Related Party Transaction [Line Items]	'	'
Amount of transaction	$40,000	'

NOTES_PAYABLE_Details

NOTES PAYABLE (Details) (USD $)	2 Months Ended		12 Months Ended
	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
			Secured Note [Member]	Amended Note [Member]
NOTES PAYABLE [Abstract]	'	'	'	'
Face value of net insurance benefits purchased through pledge agreement	'	$5,999,000	'	'
Amount of cash paid for the net insurance benefits purchased through pledge agreement	'	3,000,000	'	'
Debt Instrument [Line Items]	'	'	'	'
Face amount	'	'	2,999,000	1,500,000
Interest rate	'	4.00%	4.00%	'
Maturity date	31-Dec-13	'	11-Apr-15	'
Interest Payable	6,576	'	129,028	'
Buyback option	'	'	'	1,000,000
Buyback period	'	'	'	'12 months
Buyback amount, added monthly percentage	'	'	'	2.00%
Minimum buyback price	'	'	'	1,120,000
Required amount of qualified NIBs under the Del Mar ATA	'	$300,000,000	'	$400,000,000

STOCK_OPTIONS_Narrative_Detail

STOCK OPTIONS (Narrative) (Details) (USD $)	12 Months Ended
	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Stock options granted	2,185,000
Stock Price	$5
Stock-based compensation expense	$816,802
Unrecognized compensation cost related to stock options	$1,162,745
Unrecognized compensation cost related to stock options, weighted average service period	'2 years 4 months 17 days
Nonemployees [Member] | April 5, 2013 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares issued to nonemployees	80,000
Stock Price	$1.03
Exercise price	$0.77
Expected life	'5 years
Volatility	79.00%
Risk free rate	0.68%
Stock Options [Member] | April 1, 2013 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Stock options granted	5,000
Stock option term	'5 years
Stock Price	$1.03
Exercise price	$0.77
Expected life	'2 years 6 months
Volatility	73.00%
Risk free rate	0.30%
Stock Options [Member] | April 5, 2013 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Stock options granted	1,700,000
Stock option term	'5 years
Exercise price	$0.77
Stock Options [Member] | April 5, 2013 [Member] | Tranche One [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Stock options granted	1,500,000
Stock Price	$1.03
Exercise price	$0.77
Expected life	'3 years 6 months
Volatility	68.00%
Risk free rate	0.51%
Vesting period	'3 years
Shares vesting on grant date	937,500
Shares vesting on each anniversary	562,500
Shares vesting equally	187,500
Stock Options [Member] | April 5, 2013 [Member] | Tranche Two [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Stock options granted	200,000
Stock Price	$1.03
Exercise price	$0.77
Expected life	'3 years 6 months
Volatility	68.00%
Risk free rate	0.51%
Vesting period	'3 years
Shares vesting on grant date	50,000
Shares vesting on each anniversary	150,000
Stock Options [Member] | October 11, 2013 [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Stock options granted	400,000
Stock option term	'5 years
Stock Price	$5
Exercise price	$5
Expected life	'3 years 4 months 24 days
Volatility	68.00%
Risk free rate	0.76%
Stock Options [Member] | October 11, 2013 [Member] | Tranche One [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Vesting period	'6 months
Vesting rate	10.00%
Stock Options [Member] | October 11, 2013 [Member] | Tranche Two [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Vesting period	'36 months

STOCK_OPTIONS_Schedule_of_Stoc

STOCK OPTIONS (Schedule of Stock Option Activity) (Details) (USD $)	2 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2014
Stock option activity:	'	'
Outstanding as of March 31, 2013	'	'
Stock options granted	'	2,185,000
Exercised	'	'
Cancelled/Expired	'	'
Outstanding as of March 31, 2014	'	2,185,000
Exercisable	'	1,072,500
Weighted Average Exercise Price	'	'
Outstanding as of March 31, 2013	'	'
Granted	'	$1.54
Exercised	'	'
Cancelled/Expired	'	'
Outstanding as of March 31, 2014	'	$1.54
Exercisable	'	$1.54
Weighted Average Grant Date Fair Value	'	'
Outstanding as of March 31, 2013	'	'
Granted	'	$0.97
Exercised	'	'
Cancelled/Expired	'	'
Outstanding as of March 31, 2014	'	0.97
Exercisable	'	$0.97
Remaining Contractual Term	'	'
Granted	'	'4 years 6 months
Exercised	'	'
Outstanding	'	'
Exercisable	'	'4 years 6 months
Intrinsic Value	'	'
Outstanding as of March 31, 2013	'	'
Granted	'	$3,374,450
Exercised	'	'
Cancelled/Expired	'	'
Outstanding as of March 31, 2014	'	3,374,450
Exercisable	'	$1,656,338

WARRANTS_Narrative_Details

WARRANTS (Narrative) (Details) (USD $)	2 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2014
Class of Warrant or Right [Line Items]	'	'
Shares of common stock issuable under warrants	'	70,000
Warrant Term	'	'2 years
Offering price of shares offered through private placement	'	$5
Exercise price of warrants	'	5
Fair Value of Warrants Issued as Stock Issuance Costs	'	$139,251
Warrants [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Private placement investment amount	'	$7,000,000
Number of warrants authorized for issuance	'	70,000
Offering price of shares offered through private placement	'	$5
Expected Term	'	'2 years
Volatility	'	73.00%
Risk free rate	'	0.30%

WARRANTS_Schedule_of_Warrant_A

WARRANTS (Schedule of Warrant Activity) (Details) (USD $)	2 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2014
Number of Options	'	'
Outstanding as of March 31, 2013	'	'
Granted	'	70,000
Cancelled/Expired	'	'
Outstanding as of March 31, 2014	'	70,000
Exercisable	'	70,000
Weighted Average Exercise Price	'	'
Outstanding as of March 31, 2013	'	'
Granted	'	$5
Cancelled/Expired	'	'
Outstanding as of March 31, 2014	'	$5
Exercisable	'	$5
Weighted Average Grant Date Fair Value	'	'
Outstanding as of March 31, 2013	'	'
Granted	'	$1.92
Cancelled/Expired	'	'
Outstanding as of March 31, 2014	'	$1.92
Exercisable	'	$1.92
Remaining Contractual Term	'	'
Granted	'	'1 year 2 months 1 day
Cancelled/Expired	'	'
Remaining contractual term, outstanding shares	'	'1 year 2 months 1 day
Exercisable	'	'1 year 2 months 1 day
Intrinsic Value	'	'
Outstanding as of March 31, 2013	'	'
Granted	'	'
Cancelled/Expired	'	'
Outstanding as of March 31, 2014	'	'
Exercisable	'	'

STOCK_TRANSACTIONS_Details

STOCK TRANSACTIONS (Details) (USD $)	2 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2014
STOCK TRANSACTIONS [Abstract]	'	'
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, par value per share	$0.00	$0.00
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, shares authorized	500,000,000	500,000,000
Common Stock, par value per share	$0.00	$0.00
Common Stock, shares issued	40,797,441	43,015,941
Common Stock, shares outstanding	40,797,441	43,015,941
Maximum number of common shares of restricted stock offered through private placement	'	3,000,000
Offering price of shares offered through private placement	'	$5
Proceeds from issuance of common share issued through private placement	'	$11,792,500
Shared issued and issuable through private placement	'	2,358,500
Value of shares issued through private stock offering	3,868,740	11,092,500
Shares issued through private stock offering	'	2,218,500
Value of common stock to be issued	'	700,000
Shares to be issued	'	140,000
Payment of introduction fees	'	$841,651
Warrant Term	'	'2 years
Shares of common stock issuable under warrants	'	70,000
Exercise price of warrants	'	5

GOING_CONCERN_Details

GOING CONCERN (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013
GOING CONCERN [Abstract]	'	'
Accumulated Deficit	($310,789)	($104,651)
Working Capital	$234,297	'

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (USD $)	2 Months Ended	12 Months Ended	1 Months Ended		3 Months Ended
	Mar. 31, 2013	Mar. 31, 2014	Jul. 31, 2014	Apr. 28, 2014	Jun. 24, 2014
			Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]
Subsequent Event [Line Items]	'	'	'	'	'
Face value of loan	'	'	'	$650,000	'
Collection note receivable	'	'	'	550,000	'
Advances for investment in net insurance benefits	'	'	'	100,000	'
Shares issued through private stock offering	'	2,218,500	'	'	660,000
Value of shares issued through private stock offering	3,868,740	11,092,500	'	'	3,300,000
Share price	'	$5	'	'	$5
Shares issued for subscriptions receivable	'	'	140,000	'	'
Value of shares issued for subscriptions receivable	'	'	$700,000	'	'